Streetbeat News

Price Targets

GEHC

Mizuho analyst Anthony Petrone maintains a Buy rating on GE HealthCare Techs (NASDAQ:GEHC) and raises the price target from $94 to $96.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:49 pm

FTNT

Wedbush analyst Daniel Ives has maintained an Outperform rating on Fortinet (NASDAQ:FTNT) and increased the price target from $75 to $86.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:48 pm

FTNT

Mizuho analyst Gregg Moskowitz maintains a Neutral rating on Fortinet (NASDAQ:FTNT) and raises the price target from $60 to $70.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:46 pm

TENB

Wedbush analyst Daniel Ives maintains an Outperform rating on Tenable Holdings (NASDAQ:TENB) and raises the price target from $50 to $65.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:44 pm

EW

Mizuho analyst Anthony Petrone has maintained a Buy rating on Edwards Lifesciences (NYSE:EW) and increased the price target from $85 to $95.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:43 pm

DD

Mizuho analyst John Roberts maintains a Buy rating on DuPont de Nemours (NYSE:DD) but lowers the price target from $80 to $76 as of 6th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:42 pm

CHKP

Wedbush analyst Daniel Ives maintains an Outperform rating on Check Point Software (CHKP) and raises the price target from $170 to $185.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:40 pm

CRNC

Wedbush analyst Daniel Ives maintains a Neutral rating on Cerence (NASDAQ:CRNC) and raises the price target from $19 to $21.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:39 pm

CHKP

Mizuho analyst Gregg Moskowitz maintains a Neutral rating on Check Point Software (CHKP) and raises the price target from $150 to $160 as of 6th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:38 pm

HRB

Goldman Sachs analyst George Kelly has maintained a Sell rating on H&R Block (NYSE:HRB) but raised the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:30 pm